3.9
16 Ratings with 5 written Reviews
Summary
Born in 1948 in Manchester, England, Jonathan Finlay received his undergraduate and medical school education at the University of Birmingham, graduating in 1973. He undertook residency training in Pediatrics in Birmingham, ending with training in Pediatric Oncology at the Christie Hospital and Holt Radium Institute, Manchester, before moving to the United States in 1976. He undertook Fellowship training, first in Pediatric Immunology (1976-78) and then in Pediatric Hematology and Oncology (1978-80) at the University of Wisconsin-Madison.
During his first faculty position (Assistant Professor of Pediatrics) at Stanford University (1980-82), Dr. Finlay initiated a long-standing interest in and commitment to the problems of children with brain tumors. Upon return to Madison, Wisconsin in 1982, Dr. Finlay established the Mid-West Pediatric Brain Tumor Center, striving to coordinate the care of children with brain tumors across the region of Wisconsin, Northern Illinois and Eastern Iowa.
…In 1985, Dr. Finlay was appointed as Chairman of the Brain Tumor Strategy Group of the nation-wide Children's Cancer Group (CCG). Representing over half of all pediatric cancer centers in the United States, he oversaw the development of national treatment programs to improve the outcome for children with brain tumors. He held this position until 1992, and continues as a member of the Steering Committee for the COG Brain Tumor Strategy Group.
Dr. Finlay moved to the Children's Hospital of Philadelphia in 1987, as a Senior Physician and Associate Professor of Pediatrics of the University of Pennsylvania, continuing to develop and conduct innovative therapeutic programs for children with brain tumors, focusing on the use of myeloablative chemotherapy followed by autologous hematopoietic progenitor cell "rescue".
In 1989, Dr. Finlay moved to New York as Vice Chairman of the Department of Pediatrics at Memorial Sloan-Kettering Cancer Center (MSKCC) and Associate Professor of Pediatrics at Cornell University Medical College. During that time, he initiated innovative treatment programs for the youngest children with malignant brain tumors (The "Head Start" protocols). Additionally, he established a multi-center, multi-national consortium, the International CNS Germ Cell Tumor Study Group, which has since conducted three serial clinical trials on these rare tumors.
In October 1997, Dr. Finlay relocated to New York University Medical Center, where he became the Director of the Division of Pediatric Oncology and of the Hassenfeld Center for Cancer and Blood Diseases of Childhood, and a tenured Professor of Pediatrics at New York University. In 2002, Dr. Finlay was awarded the Julie and Edward J. Minskoff Chaired Professorship in Pediatrics (Neuro-oncology) at New York University. During his six years at New York University, the innovative treatment programs developed at MSKCC continued and expanded under his direction.
In October of 2003, Dr. Finlay moved to California as the Director of the Neural Tumors Program at Childrens Hospital Los Angeles and Professor of Pediatrics, Neurology and Neurosurgery at the Keck School of Medicine, University of Southern California. This Program is one of the largest brain tumor programs for children in North America, and is additionally one of the leading centers for the chemotherapeutic management of childhood brain tumors, with the continuing development of innovative programs, for example, (1) to avoid the use of radiation therapy for children less than six years of age newly diagnosed with malignant brain tumors, (2) to treat the rare family of brain tumors, known as germ cell tumors, in an international study (involving Argentina, Australia, the United Kingdom, Canada and the U.S.) with chemotherapy alone, and (3) to treat otherwise incurable brain tumors that have recurred following initial treatments, with myeloablative chemotherapy and autologous hematopoietic progenitor cell rescue.
Dr. Finlay is internationally recognized as a leading authority in the management of children with brain tumors.
Read More Read less During his first faculty position (Assistant Professor of Pediatrics) at Stanford University (1980-82), Dr. Finlay initiated a long-standing interest in and commitment to the problems of children with brain tumors. Upon return to Madison, Wisconsin in 1982, Dr. Finlay established the Mid-West Pediatric Brain Tumor Center, striving to coordinate the care of children with brain tumors across the region of Wisconsin, Northern Illinois and Eastern Iowa.
…In 1985, Dr. Finlay was appointed as Chairman of the Brain Tumor Strategy Group of the nation-wide Children's Cancer Group (CCG). Representing over half of all pediatric cancer centers in the United States, he oversaw the development of national treatment programs to improve the outcome for children with brain tumors. He held this position until 1992, and continues as a member of the Steering Committee for the COG Brain Tumor Strategy Group.
Dr. Finlay moved to the Children's Hospital of Philadelphia in 1987, as a Senior Physician and Associate Professor of Pediatrics of the University of Pennsylvania, continuing to develop and conduct innovative therapeutic programs for children with brain tumors, focusing on the use of myeloablative chemotherapy followed by autologous hematopoietic progenitor cell "rescue".
In 1989, Dr. Finlay moved to New York as Vice Chairman of the Department of Pediatrics at Memorial Sloan-Kettering Cancer Center (MSKCC) and Associate Professor of Pediatrics at Cornell University Medical College. During that time, he initiated innovative treatment programs for the youngest children with malignant brain tumors (The "Head Start" protocols). Additionally, he established a multi-center, multi-national consortium, the International CNS Germ Cell Tumor Study Group, which has since conducted three serial clinical trials on these rare tumors.
In October 1997, Dr. Finlay relocated to New York University Medical Center, where he became the Director of the Division of Pediatric Oncology and of the Hassenfeld Center for Cancer and Blood Diseases of Childhood, and a tenured Professor of Pediatrics at New York University. In 2002, Dr. Finlay was awarded the Julie and Edward J. Minskoff Chaired Professorship in Pediatrics (Neuro-oncology) at New York University. During his six years at New York University, the innovative treatment programs developed at MSKCC continued and expanded under his direction.
In October of 2003, Dr. Finlay moved to California as the Director of the Neural Tumors Program at Childrens Hospital Los Angeles and Professor of Pediatrics, Neurology and Neurosurgery at the Keck School of Medicine, University of Southern California. This Program is one of the largest brain tumor programs for children in North America, and is additionally one of the leading centers for the chemotherapeutic management of childhood brain tumors, with the continuing development of innovative programs, for example, (1) to avoid the use of radiation therapy for children less than six years of age newly diagnosed with malignant brain tumors, (2) to treat the rare family of brain tumors, known as germ cell tumors, in an international study (involving Argentina, Australia, the United Kingdom, Canada and the U.S.) with chemotherapy alone, and (3) to treat otherwise incurable brain tumors that have recurred following initial treatments, with myeloablative chemotherapy and autologous hematopoietic progenitor cell rescue.
Dr. Finlay is internationally recognized as a leading authority in the management of children with brain tumors.
Quick Facts
- 53 years of experience
- 33 insurance plans accepted
- University Of Wisconsin Hospital
- 5 written reviews
- 2 specialties
- 22 areas of expertise
- 2 board certifications
- 1 hospital affiliation
- 1 office location
- Male
Office Location
Compare with Similar Doctors
 |  |  |  |
| Dr. Jonathan Lester Finlay, MD | Dr. Tamar Heisler | Dr. Tracy Ching-Hue Burton | Dr. Mary Medina Nave, MD |
| Pediatrics | Pediatrics | Pediatrics | Pediatrics |
| Accepts New Patients | Accepts New Patients | ||
| 53 Years of Experience | 18 Years of Experience | 18 Years of Experience | 33 Years of Experience |
| No Virtual Visit Option | Virtual Visit Available | Virtual Visit Available | No Virtual Visit Option |
| Speaks English | Speaks Chinese, Spanish | Speaks Spanish, English | |
| NIPOMO , CA | Franklin , TN | Franklin , TN | San Luis Obispo , CA |
| Med School: University Of Birmingham College Of Medical And Dental Sciences | Med School: Sackler School of Medicine -- Tel-Aviv University | Med School: University Of Alabama School Of Medicine | Med School: University Of California San Diego School Of Medicine |
Current Profile | View Profile | View Profile | View Profile |
Insurance Plans Accepted by Dr. Jonathan Lester Finlay
Medical Specialties
Dr. Jonathan Lester Finlay has the following 2 specialties
Specialty Expertise
Dr. Jonathan Lester Finlay has the following 22 areas of expertise
Certifications, License, & Education
53 Years Experience
MEDICAL LICENSE
Medical Doctor, California, Active
EDUCATION & TRAINING
Residency
University Of Wisconsin Hospital
Medical School
University Of Birmingham College Of Medical And Dental SciencesGraduated in 1973
Similar doctors
Frequently Asked Questions
- Is Dr. Jonathan Finlay accepting new patients?
- Dr. Jonathan Finlay has not indicated that they accept new patients. Contact their office through their Vitals profile to check for availability.
- Does Dr. Jonathan Finlay accept my insurance?
- You can see the insurance plans that Dr. Jonathan Finlay accepts on their Vitals profile.
- Does Dr. Jonathan Finlay accept virtual/telehealth appointments?
- Dr. Jonathan Finlay has not indicated that they accept virtual/teleheatlh appointments. Contact their office through their Vitals profile to check for availability.
- Which hospitals is Dr. Jonathan Finlay affiliated with?
- Dr. Jonathan Finlay is affiliated with Nationwide Childrens Hospital.
- How can I make an appointment with Dr. Jonathan Finlay?
- You can find contact information for Dr. Jonathan Finlay here on Vitals.
Ensuring Data Transparency and Trust: A Guide to Vitals Doctor Listings and Reviews
Our provider data is gathered directly from physicians and publicly available databases. Providers who verify their profiles gain the ability to update information, offering additional details about their specialties,education, treated conditions, performed procedures, and accepted insurances.
Reviews on Vitals are submitted by users only. Recognizing the valuable insights these reviews offer into a doctor's reputation, we maintain internal policies and protocols to ensure the quality and accuracy of all reviews. Importantly, providers cannot delete or alter reviews independently. Reviews can only be deleted or changed following an internal assessment by our customer service team.
Your feedback is highly valued and we encourage you to contact our support team should you encounter any issues.
